PROVIDER PROFILE · NPI 1669667366

Caroline Groft MacfarlaneMD, PHD

PRACTICERENAL CARE GROUP EAST, INC.See all providers at this practice →

DermatologyWynnewood, PAI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,801

Unique beneficiaries

—

Total services

5,724

Distinct HCPCS

Medicare payment

$231K

Peer benchmark

Total Medicare services vs. 531 Dermatology providers in PA — top quintile (cohort median 2,070).

PRESCRIBING · PART D · 2024

Total Rx claims

971

Beneficiaries

—

Total drug cost

$23K

Distinct drugs

Brand share

1.9%

Top prescribed drugs

Ketoconazole219 claims

Triamcinolone Acetonide156 claims

Clobetasol Propionate99 claims

Minoxidil95 claims

Finasteride63 claims

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$876

Payment records

By payment type

Food and Beverage$876

REFERRAL NETWORK

Where Caroline Groft Macfarlane's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 5 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
MAIN LINE HOSPITALS, INC.	110	206
John Seykora Dermatology · Philadelphia, PA	72	95
Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Norristown, PA	62	85
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	13	25
Adam Rubin Dermatology · New York, NY	13	15

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history